Allergic rhinitis (AR) is an IgE-mediated type 1 hypersensitivity reaction of nasal mucosa in response to an antigenic substance (allergen).^[@bibr1-2473974X17742648],[@bibr2-2473974X17742648]^ It is a common disorder among children. In Nigeria, the prevalence of AR among children with asthma was 39.2%.^[@bibr3-2473974X17742648]^ No study has reported the prevalence of AR in the general pediatric age group in the country. Many factors may predispose already genetically predisposed individuals to AR, including family history of allergy, overcrowding, dusty environment, air-conditioned rooms, and so on.^[@bibr1-2473974X17742648]^ Recent evidence suggested that the disorder is relatively more common among children of affluent parents who live in purportedly hygienic environments.^[@bibr4-2473974X17742648][@bibr5-2473974X17742648]-[@bibr6-2473974X17742648]^ The symptomatology of AR includes clear mucoid nasal discharge, itching, bouts of sneezing, and nasal obstruction,^[@bibr7-2473974X17742648]^ which are reversible either spontaneously or following the use of antiallergic medications. These symptoms are precipitated by exposure to allergens, with hypersensitivity to multiple antigens more common than hypersensitivity to a single antigen.^[@bibr8-2473974X17742648]^

The allergic inflammation of nasal mucosa readily spreads to involve contiguous and distant organs, such as eustachian tube, middle ear, and upper and lower airways. AR has a strong association with asthma, atopic dermatitis, conjunctivitis, nasal polyps, and sleep disorder.^[@bibr2-2473974X17742648],[@bibr9-2473974X17742648][@bibr10-2473974X17742648]-[@bibr11-2473974X17742648]^ It can also cause a dysfunctional eustachian tube with resultant otitis media with effusion (OME).^[@bibr12-2473974X17742648],[@bibr13-2473974X17742648]^ The burden of AR is significant and includes loss of school, absence from work, and economic loss. Furthermore, the presence of OME in a child may affect his or her hearing,^[@bibr14-2473974X17742648],[@bibr15-2473974X17742648]^ thereby causing delayed speech and language development as well as poor academic performance at school. It may also affect one's social interaction with peers in the environment because of difficulty in communication. Many children have been wrongly labeled stubborn and abused, especially when they failed to carry out instructions.

Some developmental sequelae of OME, particularly deficits in reading ability, can persist into late childhood and the early teens.^[@bibr16-2473974X17742648]^ It is therefore important to promptly identify children with AR with OME and manage their cases to reduce the burden of hearing loss. Therefore, the aim of this study was to determine the prevalence of OME among children with AR and describe the different patterns of tympanograms seen among children in Ibadan, Nigeria.

Materials and Methods {#section7-2473974X17742648}
=====================

This case-control study included children (2-7 years old) with AR treated at the University College Hospital, Ibadan. The clinical diagnosis of AR was based on the presence of watery nasal discharge and at least 1 of excessive bout of sneezing, nasal obstruction, and nasal itching for a minimum of 3 to 4 weeks following onset of symptoms^[@bibr17-2473974X17742648][@bibr18-2473974X17742648][@bibr19-2473974X17742648]-[@bibr20-2473974X17742648]^ and was further confirmed with nasal cytology (nasal smear for eosinophils).^[@bibr21-2473974X17742648],[@bibr22-2473974X17742648]^ The control group comprised healthy children from the University College Hospital Staff School without features of allergy and rhinosinusitis. None of the participants had symptoms or signs of acute otitis media.

The Ethics Review Committee of the joint University of Ibadan--University College Hospital approved the study. Informed consent was also obtained from the parents or caregivers of the participants.

Data Collection Procedure {#section8-2473974X17742648}
-------------------------

### Structured Questionnaire {#section9-2473974X17742648}

The questionnaire was administered to the parents or caregivers of the participants to obtain data on sociodemographics, symptoms, duration of AR, and comorbidities. The skin, eyes, ear, nose, and throat were examined. Children with earwax had it removed, but those with ear discharge and/or perforated tympanic membrane as well as features of adenoid vegetation (confirmed by lateral postnasal radiograph) were excluded from the study.

### Nasal Smear for Eosinophils {#section10-2473974X17742648}

Under adequate illumination, the anterosuperior part of the inferior turbinate was swabbed, smeared on a glass slide, processed, and examined microscopically at the Department of Pathology, University College Hospital, for the presence of eosinophils or other inflammatory cells. The presence of at least 5 eosinophilic cells under the high-power field of a light microscope was diagnostic of AR.^[@bibr21-2473974X17742648][@bibr22-2473974X17742648]-[@bibr23-2473974X17742648]^

### Tympanometry {#section11-2473974X17742648}

Tympanometry was performed with a Welch Allyn Autotymp (TM 262, version 4, 2008), manufactured and calibrated by Welch Allyn (Skaneateles Falls, New York) to standards per the International Organization for Standardization, with a probe tone frequency of 226 Hz (sound pressure level, +200 to −400 daPa). Tympanogram was then classified according to modified Jerger's classification.^[@bibr24-2473974X17742648]^ In this study, type B or C tympanogram was diagnostic of OME.

### Data Analysis and Presentation {#section12-2473974X17742648}

Data collected were collated and inputted into SPSS 17 (IBM, Chicago, Illinois) for analysis. Frequencies, percentages, and cross tabulations were used to summarize qualitative variables. Differences among categorical variables were analyzed with the chi-square test, while Student's *t* test was used to analyze difference among continuous variables. A *P* value \<.05 was accepted to be statistically significant.

Results {#section13-2473974X17742648}
=======

A total 172 children were studied, including 86 children with AR (male: n = 58, 67.4%; female: n = 28, 32.6%) and 86 controls (male: n = 59, 68.6%; female: n = 27, 31.4%). The age of the patients with AR ranged from 2 to 7 years (mean ± SD, 3.80 ± 1.72 years), and the age of the controls ranged from 2 to 7 years (3.78 ± 1.71 years).

The mean duration of AR symptoms was 18 ± 13 months. All the children with AR presented with watery nasal discharge, nasal obstruction, and nasal itching (frequent rubbing of the nose). Only 57 (66.3%) children with AR presented with an excessive bout of sneezing. Comorbidities among the participants with AR included bronchial asthma (n = 28, 32.6%), allergic dermatitis (n = 30, 34.9%), and allergic conjunctivitis (n = 15, 17.4%; [**Table 1**](#table1-2473974X17742648){ref-type="table"}). There was a significant association of AR with bronchial asthma (*P* = .033), allergic dermatitis (*P* = .002), and allergic conjunctivitis (*P* = .007).

###### 

Comorbidities of Allergic Rhinitis among the Cases.

![](10.1177_2473974X17742648-table1)

  Comorbidity               Cases, n (%)   *P* Value
  ------------------------- -------------- -----------
  Bronchial asthma          28 (32.6)      .033
  Allergic dermatitis       30 (34.9)      .002
  Allergic conjunctivitis   15 (17.4)      .007

There was a significant difference in the family history of atopy between the groups ([**Table 2**](#table2-2473974X17742648){ref-type="table"}).

###### 

Family History of Atopy among the Cases and Controls.^[a](#table-fn1-2473974X17742648){ref-type="table-fn"}^

![](10.1177_2473974X17742648-table2)

  Allergic Disorder         Cases       Controls    *P* Value
  ------------------------- ----------- ----------- -----------
  Bronchial asthma          61 (70.9)   11 (12.8)   .0001
  Allergic dermatitis       26 (30.2)   8 (9.3)     .0001
  Allergic rhinitis         38 (44.2)   12 (14.0)   .0001
  Allergic conjunctivitis   22 (25.6)   9 (10.5)    .001

Values are presented as n (%).

Among the cases and controls, Jerger's type A tympanogram was the most common pattern in both ears, while type C was the least common, as shown in [**Table 3**](#table3-2473974X17742648){ref-type="table"}.

###### 

Pattern of Tympanograms among the Cases and Controls.^[a](#table-fn2-2473974X17742648){ref-type="table-fn"}^

![](10.1177_2473974X17742648-table3)

  Ear: Tympanogram   Cases       Control     χ^[@bibr2-2473974X17742648]^   *P* Value
  ------------------ ----------- ----------- ------------------------------ -----------
  Right ear                                  21.3                           \<.001
   Type A            57 (66.3)   82 (95.4)                                  
   Type B            23 (26.7)   2 (2.3)                                    
   Type C            6 (7.0)     2 (2.3)                                    
  Left ear                                   20.8                           \<.001
   Type A            52 (60.5)   83 (96.5)                                  
   Type B            24 (27.9)   2 (2.3)                                    
   Type C            10 (11.6)   1 (1.2)                                    

Values are presented as n (%).

Thirty-nine (45.3%) participants with AR had OME, as compared with 8 (9.3%) controls, and the difference was statistically significant (*P* \< .001; odds ratio = 8.090; 95% CI = 3.48-18.79), as shown in [**Table 4**](#table4-2473974X17742648){ref-type="table"}.

###### 

Prevalence of OME among the Participants.^[a](#table-fn4-2473974X17742648){ref-type="table-fn"}^

![](10.1177_2473974X17742648-table4)

  OME          Cases       Control     Odds Ratio   McNemar   95% CI       *P* Value
  ------------ ----------- ----------- ------------ --------- ------------ -----------
  Unilateral   15 (17.4)   8 (9.3)     8.09         26.3      3.48-18.79   \<.001
  Bilateral    24 (27.9)   0 (0.0)                                         
  None         47 (54.7)   78 (90.7)                                       

Abbreviation: OME, otitis media with effusion.

Values are presented as n (%).

Discussion {#section14-2473974X17742648}
==========

This present study clearly showed that OME occurred more among the participants with AR than the age- and sex-matched healthy (nonallergic) controls. To the best of our knowledge, this study is the first to investigate the pattern of tympanometry among children with AR in Nigeria. The prevalence of OME (45.3%) in the present study was higher than that cited in similar pediatric studies: 32.8% by Alles et al^[@bibr25-2473974X17742648]^ and 39% in a Copenhagen study.^[@bibr26-2473974X17742648]^ The reason for the observed difference is unknown but may be associated with the genetic makeup and environmental differences of the studied population. The present study found that children with AR have \>8 times the chance of developing OME (*P* \< .001; odds ratio = 8.090; 95% CI = 3.48-18.79). The Copenhagen cohort study reported 3-fold chances of children with AR developing OME as compared with the unaffected child population. The higher prevalence of OME among children with AR may not be unconnected with the inflammatory process in the nasal mucosa, which spreads easily to involve the mucosa of the eustachian tube and middle ear cleft, thereby resulting in eustachian tube dysfunction and OME.

The male preponderance of AR in this study is similar to what the literature has reported.^[@bibr3-2473974X17742648]^ Although allergic disorder majorly affects a single organ, it could affect \>1 organ, resulting in more severe effects. The comorbidities reported in this study---allergic dermatitis, bronchial asthma, and allergic conjunctivitis---are similar to what other studies on AR have reported.^[@bibr17-2473974X17742648],[@bibr19-2473974X17742648],[@bibr27-2473974X17742648],[@bibr28-2473974X17742648]^ Positive family history of atopy has been documented as a recognized risk factor for the development of AR,^[@bibr28-2473974X17742648]^ as corroborated by the finding in this study where more cases than controls had a family history of atopy.

The pattern of tympanogram recorded in this study included Jerger's tympanogram types A, B, and C, similar to what similar studies have reported.^[@bibr29-2473974X17742648],[@bibr30-2473974X17742648]^ Tympanogram type A was the most common in this study and was usually found in a healthy middle ear cleft. However, it could also be found at the early stage of OME. This study had a higher proportion of cases with a type B pattern than a type C pattern. Tympanogram type C indicates dysfunction in the eustachian tube, while type B implies the presence of effusion in the middle ear cleft or the restriction of tympanic membrane mobility. The higher proportion of children with type B than type C may not be unconnected with the fact that the disease process of OME usually starts with blockage of the eustachian tube by mucosa edema or a plug of thick, tenacious mucus.

AR manifests with excessive bouts of sneezing, nasal mucous secretion, and edematous swelling of the mucosal lining of nasal cavity, nasopharynx, and eustachian tube.^[@bibr12-2473974X17742648]^ The pathogenesis of OME and hearing loss in children with AR is associated with dysfunction of the eustachian tube when partially or completely obstructed by a mucous plug or mucosal edema. In this situation, air within the middle ear cleft is absorbed by the mucous membrane and is not replaced, resulting in negative middle ear pressure. The sustained negative pressure results in a retracted tympanic membrane and eventual secretion and retention of fluid within the middle ear space resulting in OME. OME has a negative effect on the auditory process, with a consequent clinical manifestation as conductive hearing loss.^[@bibr12-2473974X17742648]^

The 2016 updated clinical practice guideline for diagnosing OME from the American Academy of Otolaryngology---Head and Neck Surgery Foundation recommends the use of pneumatic otoscopy to document the presence of OME in children before tympanometry, as well as to assess for OME among children with otalgia, hearing loss, or both.^[@bibr31-2473974X17742648]^ Unfortunately, this was not done in this study due to the nonavailability of a functioning pneumatic otoscope at the time. Nevertheless, the tympanometry done confirmed OME in the children. None of the participants had otalgia, and caregivers did not lodge complaints of hearing loss on their wards. However, the focus of the study did not include documentation on speech delay, which is the sequela of OME. The presence of nasal eosinophilia alone to confirm AR in this study is inadequate, as this can also be found in non-AR with eosinophilia syndrome. However, allergen skin testing, which can distinguish AR from non-AR with eosinophilia syndrome, could not be done due to funding and, thus, the difficulty in procuring allergen test kits.

Conclusion {#section15-2473974X17742648}
==========

The prevalence of OME in this study was 45.3%. Three tympanometric patterns as described by Jerger were seen, but the abnormal patterns (types B and C) were more common for children with AR than the healthy pediatric population. Medical practitioners should be aware of the possible association of AR with OME and hence incorporate routine tympanometric evaluation into the management protocol for children with AR to detect and treat OME early.
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